Return to study ST001211 main page   Show: (1)HMDB and KEGG pathways   (2)REACTOME pathways containing these metabolites

Select	Metabolite Name	Metabolite Id	Refmet Name	Ret. Index	Quant. m/z	Analysis Display
	GlcCer(d14:1(4E)/20:0(2OH))	ME288501	GlcCer 14:1;O2(4E)/20:0;O	5.025	714.5551	Reversed phase NEGATIVE ION MODE
	GlcCer (d40:1)	ME288497	GlcCer 40:1;O2	7.275	818.6293	Reversed phase NEGATIVE ION MODE
	GlcCer (d41:1)	ME288498	GlcCer 41:1;O2	7.61	832.644	Reversed phase NEGATIVE ION MODE
	GlcCer (d42:1)	ME288499	GlcCer 42:1;O2	7.93	846.6606	Reversed phase NEGATIVE ION MODE
	GlcCer (d42:2)	ME288500	GlcCer 42:2;O2	7.25	844.6464	Reversed phase NEGATIVE ION MODE
	GlcCer(d34:1)	ME288195	GlcCer 34:1;O2	4.866666667	862.6236	Reversed phase POSITIVE ION MODE
	GlcCer(d40:1)	ME288196	GlcCer 40:1;O2	7.11	784.6645	Reversed phase POSITIVE ION MODE
	GlcCer(d42:1)	ME288197	GlcCer 42:1;O2	7.76	812.6954	Reversed phase POSITIVE ION MODE
	GlcCer(d42:2)	ME288198	GlcCer 42:2;O2	7.083333333	810.6809	Reversed phase POSITIVE ION MODE
	Lactosylceramide (d18:1/24:1(15Z))	ME288199	LacCer 18:1;O2/24:1	6.81	972.7347	Reversed phase POSITIVE ION MODE